KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) EBT Margin: 2010-2025

Historic EBT Margin for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -288.22%.

  • Novavax's EBT Margin fell 14347.00% to -288.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 35.05%, marking a year-over-year increase of 6666.00%. This contributed to the annual value of -25.89% for FY2024, which is 2931.00% up from last year.
  • Novavax's EBT Margin amounted to -288.22% in Q3 2025, which was down 569.39% from 61.40% recorded in Q2 2025.
  • Over the past 5 years, Novavax's EBT Margin peaked at 77.98% during Q1 2025, and registered a low of -373.39% during Q4 2021.
  • Moreover, its 3-year median value for EBT Margin was -70.31% (2023), whereas its average is -88.28%.
  • Its EBT Margin has fluctuated over the past 5 years, first spiked by 71,676bps in 2021, then plummeted by 39,088bps in 2023.
  • Quarterly analysis of 5 years shows Novavax's EBT Margin stood at -373.39% in 2021, then spiked by 32,177bps to -51.63% in 2022, then tumbled by 903bps to -60.65% in 2023, then crashed by 2,267bps to -83.32% in 2024, then slumped by 14,347bps to -288.22% in 2025.
  • Its EBT Margin stands at -288.22% for Q3 2025, versus 61.40% for Q2 2025 and 77.98% for Q1 2025.